A detailed history of Greenwich Wealth Management LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Greenwich Wealth Management LLC holds 14,222 shares of ABBV stock, worth $2.43 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares
14,222
Previous 14,188 0.24%
Holding current value
$2.43 Million
Previous $2.43 Million 15.41%
% of portfolio
0.19%
Previous 0.18%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

BUY
$163.84 - $199.33 $5,570 - $6,777
34 Added 0.24%
14,222 $2.81 Million
Q2 2024

Aug 09, 2024

SELL
$154.79 - $180.76 $928 - $1,084
-6 Reduced 0.04%
14,188 $2.43 Million
Q1 2024

May 13, 2024

BUY
$159.82 - $182.1 $18,539 - $21,123
116 Added 0.82%
14,194 $2.59 Million
Q4 2023

Feb 01, 2024

SELL
$137.6 - $154.97 $11,283 - $12,707
-82 Reduced 0.58%
14,078 $2.18 Million
Q3 2023

Nov 07, 2023

BUY
$133.59 - $154.65 $132,788 - $153,722
994 Added 7.55%
14,160 $2.11 Million
Q2 2023

Jul 31, 2023

SELL
$132.51 - $164.9 $25,044 - $31,166
-189 Reduced 1.42%
13,166 $1.77 Million
Q1 2023

Apr 24, 2023

BUY
$144.61 - $166.54 $6,073 - $6,994
42 Added 0.32%
13,355 $2.13 Million
Q4 2022

Feb 06, 2023

BUY
$138.31 - $165.87 $54,909 - $65,850
397 Added 3.07%
13,313 $2.15 Million
Q3 2022

Nov 14, 2022

SELL
$134.21 - $153.93 $94,349 - $108,212
-703 Reduced 5.16%
12,916 $1.73 Million
Q2 2022

Aug 08, 2022

BUY
$137.62 - $174.96 $96,746 - $122,996
703 Added 5.44%
13,619 $2.09 Million
Q1 2022

May 11, 2022

SELL
$131.98 - $163.75 $3,695 - $4,585
-28 Reduced 0.22%
12,916 $2.09 Million
Q4 2021

Jan 28, 2022

BUY
$107.43 - $135.93 $2,041 - $2,582
19 Added 0.15%
12,944 $1.75 Million
Q3 2021

Oct 19, 2021

BUY
$106.4 - $120.78 $107,464 - $121,987
1,010 Added 8.48%
12,925 $1.39 Million
Q2 2021

Jul 27, 2021

SELL
$105.21 - $117.21 $91,532 - $101,972
-870 Reduced 6.8%
11,915 $1.34 Million
Q1 2021

May 06, 2021

BUY
$102.3 - $112.62 $37,032 - $40,768
362 Added 2.91%
12,785 $1.38 Million
Q4 2020

Feb 12, 2021

BUY
$80.49 - $108.67 $42,740 - $57,703
531 Added 4.47%
12,423 $1.33 Million
Q3 2020

Oct 29, 2020

BUY
$85.91 - $100.83 $429 - $504
5 Added 0.04%
11,892 $1.04 Million
Q2 2020

Aug 11, 2020

BUY
$73.37 - $98.18 $16,288 - $21,795
222 Added 1.9%
11,887 $1.17 Million
Q1 2020

May 12, 2020

BUY
$64.5 - $97.79 $752,392 - $1.14 Million
11,665 New
11,665 $889,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $302B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Greenwich Wealth Management LLC Portfolio

Follow Greenwich Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Greenwich Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Greenwich Wealth Management LLC with notifications on news.